Showing results (361-370 of 372) with videos related to

Sort By:
Pageof 38
Pharmacology & Therapeutics|November 7, 2024
Lessons learned from 20 years of preclinical testing in pediatric cancersMalcolm A Smith, Peter J Houghton, Richard B Lock, et al.
Molecular Cancer Therapeutics|August 7, 2023
Targeted Investigational Oncology Agents in the NCI-60: A Phenotypic Systems-based ResourceJoel Morris, Mark W Kunkel, Stephen L White, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 23, 2021
The B7-H3-Targeting Antibody-Drug Conjugate m276-SL-PBD Is Potently Effective Against Pediatric Cancer Preclinical Solid Tumor ModelsNathan M Kendsersky, Jarrett Lindsay, E Anders Kolb, et al.
The American Journal of Pathology|July 28, 2004
Vascular gene expression in nonneoplastic and malignant brainStephen L Madden, Brian P Cook, Mariana Nacht, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2018
Broad Spectrum Activity of the Checkpoint Kinase 1 Inhibitor Prexasertib as a Single Agent or Chemopotentiator Across a Range of Preclinical Pediatric Tumor ModelsCaitlin D Lowery, Michele Dowless, Matthew Renschler, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
Lamin A/C Deficiency Drives Genomic Instability and Poor Survival in Small-Cell Lung Cancer through Increased R-loop AccumulationChristopher W Schultz, Sourav Saha, Anjali Dhall, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2026
PRECLINICAL ACTIVITY OF THE B7-H3- TARGETING ANTIBODY-DRUG CONJUGATE (ADC) VOBRAMITAMAB DUOCARMAZINE (VOBRA DUO) IN PEDIATRIC SOLID TUMORSEdward Favours, Haiying Tang, Peyton Wong, et al.
Nature Biotechnology|October 27, 2015
Comprehensive characterization of the Published Kinase Inhibitor SetJonathan M Elkins, Vita Fedele, Marta Szklarz, et al.
Cancer Cell|December 11, 2019
A Menin-MLL Inhibitor Induces Specific Chromatin Changes and Eradicates Disease in Models of MLL-Rearranged LeukemiaAndrei V Krivtsov, Kathryn Evans, Jayant Y Gadrey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2014
Toward a drug development path that targets metastatic progression in osteosarcomaChand Khanna, Timothy M Fan, Richard Gorlick, et al.
Pageof 38